• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母源性 20 号染色体单亲二体(UPD(20)mat)作为 Silver-Russell 综合征的鉴别诊断:三例新病例的鉴定。

Maternal Uniparental Disomy of Chromosome 20 (UPD(20)mat) as Differential Diagnosis of Silver Russell Syndrome: Identification of Three New Cases.

机构信息

Research Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20095 Milan, Italy.

Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

出版信息

Genes (Basel). 2021 Apr 17;12(4):588. doi: 10.3390/genes12040588.

DOI:10.3390/genes12040588
PMID:33920573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8073552/
Abstract

Silver Russell Syndrome (SRS, MIM #180860) is a rare growth retardation disorder in which clinical diagnosis is based on six features: pre- and postnatal growth failure, relative macrocephaly, prominent forehead, body asymmetry, and feeding difficulties (Netchine-Harbison clinical scoring system (NH-CSS)). The molecular mechanisms consist in (epi)genetic deregulations at multiple loci: the loss of methylation (LOM) at the paternal :IG-DMR (chr11p15.5) (50%) and the maternal uniparental disomy of chromosome 7 (UPD(7)mat) (10%) are the most frequent causes. Thus far, about 40% of SRS remains undiagnosed, pointing to the need to define the rare mechanisms in such a consistent fraction of unsolved patients. Within a cohort of 176 SRS with an NH-CSS ≥ 3, a molecular diagnosis was disclosed in about 45%. Among the remaining patients, we identified in 3 probands (1.7%) with UPD(20)mat (Mulchandani-Bhoj-Conlin syndrome, OMIM #617352), a molecular mechanism deregulating the locus and described in 21 cases, characterized by severe feeding difficulties associated with failure to thrive, preterm birth, and intrauterine/postnatal growth retardation. Our patients share prominent forehead, feeding difficulties, postnatal growth delay, and advanced maternal age. Their clinical assessment and molecular diagnostic flowchart contribute to better define the characteristics of this rare imprinting disorder and to rank UPD(20)mat as the fourth most common pathogenic molecular defect causative of SRS.

摘要

Silver Russell 综合征(SRS,MIM #180860)是一种罕见的生长发育迟缓疾病,其临床诊断基于六个特征:产前和产后生长发育不良、相对大头畸形、前额突出、身体不对称和喂养困难(Netchine-Harbison 临床评分系统(NH-CSS))。分子机制包括多个基因座的(表观)遗传调控失调:父系:IG-DMR(chr11p15.5)的甲基化丧失(LOM)(50%)和母系 7 号染色体单亲二倍体(UPD(7)mat)(10%)是最常见的原因。迄今为止,大约 40%的 SRS 仍然无法诊断,这表明需要在如此大比例的未解决患者中定义罕见的机制。在一个 NH-CSS≥3 的 176 名 SRS 患者队列中,约有 45%的患者发现了分子诊断。在其余患者中,我们在 3 名具有 UPD(20)mat 的先证者(Mulchandani-Bhoj-Conlin 综合征,OMIM #617352)中发现了一种分子机制,该机制会调节 基因座,该机制已在 21 例中得到描述,其特征为严重的喂养困难与生长不良、早产和宫内/产后生长迟缓相关。我们的患者具有共同的突出前额、喂养困难、出生后生长延迟和高龄产妇。他们的临床评估和分子诊断流程图有助于更好地定义这种罕见的印迹障碍的特征,并将 UPD(20)mat 列为导致 SRS 的第四种最常见的致病性分子缺陷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/77491ef96c43/genes-12-00588-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/8750c2728e7d/genes-12-00588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/c4cbe8b56fda/genes-12-00588-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/77491ef96c43/genes-12-00588-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/8750c2728e7d/genes-12-00588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/c4cbe8b56fda/genes-12-00588-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/77491ef96c43/genes-12-00588-g003.jpg

相似文献

1
Maternal Uniparental Disomy of Chromosome 20 (UPD(20)mat) as Differential Diagnosis of Silver Russell Syndrome: Identification of Three New Cases.母源性 20 号染色体单亲二体(UPD(20)mat)作为 Silver-Russell 综合征的鉴别诊断:三例新病例的鉴定。
Genes (Basel). 2021 Apr 17;12(4):588. doi: 10.3390/genes12040588.
2
Mosaic Segmental and Whole-Chromosome Upd(11)mat in Silver-Russell Syndrome.银-罗素综合征中的镶嵌性节段性和整条染色体 UPD(11)mat。
Genes (Basel). 2021 Apr 16;12(4):581. doi: 10.3390/genes12040581.
3
Molecular and clinical analyses of two patients with UPD(16)mat detected by screening 94 patients with Silver-Russell syndrome phenotype of unknown aetiology.通过对 94 名病因不明的 Silver-Russell 综合征表型患者进行筛查,发现了两名患者存在 UPD(16)mat,对其进行了分子和临床分析。
J Med Genet. 2019 Jun;56(6):413-418. doi: 10.1136/jmedgenet-2018-105463. Epub 2018 Sep 21.
4
Contribution of gene mutations to Silver-Russell syndrome phenotype: multigene sequencing analysis in 92 etiology-unknown patients.基因突变对 Silver-Russell 综合征表型的影响:92 例病因不明患者的多基因测序分析。
Clin Epigenetics. 2020 Jun 16;12(1):86. doi: 10.1186/s13148-020-00865-x.
5
Maternal Uniparental Disomy for Chromosome 20: Physical and Endocrinological Characteristics of Five Patients.母源性 20 号染色体单亲二体:五名患者的体格和内分泌学特征。
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2083-2088. doi: 10.1210/jc.2017-02780.
6
upd(20)mat is a rare cause of the Silver-Russell-syndrome-like phenotype: Two unrelated cases and screening of large cohorts.upd(20)mat 是一种罕见的导致 Silver-Russell 综合征样表型的原因:两个不相关的病例及大样本筛查。
Clin Genet. 2020 Jun;97(6):902-907. doi: 10.1111/cge.13727. Epub 2020 Mar 11.
7
Examinations of maternal uniparental disomy and epimutations for chromosomes 6, 14, 16 and 20 in Silver-Russell syndrome-like phenotypes.对具有Silver-Russell综合征样表型的6号、14号、16号和20号染色体的母源单亲二倍体和表观突变的检测。
BMC Med Genet. 2016 Mar 11;17:20. doi: 10.1186/s12881-016-0280-8.
8
Frequency and clinical characteristics of distinct etiologies in patients with Silver-Russell syndrome diagnosed based on the Netchine-Harbison clinical scoring system.基于 Netchine-Harbison 临床评分系统诊断的 Silver-Russell 综合征患者不同病因的频率和临床特征。
J Hum Genet. 2022 Oct;67(10):607-611. doi: 10.1038/s10038-022-01048-7. Epub 2022 May 24.
9
Silver-Russell SyndromeSilver-Russell综合征
10
Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype.两名具有Silver-Russell综合征兼容表型的患者14q32.2印记区域的IG-DMR和MEG3-DMR的表型突变
Eur J Hum Genet. 2015 Aug;23(8):1062-7. doi: 10.1038/ejhg.2014.234. Epub 2014 Nov 5.

引用本文的文献

1
Heterodisomy in the locus is also a cause of pseudohypoparathyroidism type 1B (iPPSD3).该位点的异源二体也是1B型假性甲状旁腺功能减退症(iPPSD3)的一个病因。
Front Endocrinol (Lausanne). 2024 Dec 16;15:1505244. doi: 10.3389/fendo.2024.1505244. eCollection 2024.
2
Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver-Russell Syndrome and Focus on the IGF1R Gene.鉴别Silver-Russell综合征中的基因改变与(表观)突变并聚焦于IGF1R基因。
J Clin Endocrinol Metab. 2025 Mar 17;110(4):e932-e944. doi: 10.1210/clinem/dgae730.
3
A long way to syndromic short stature.

本文引用的文献

1
Role of Imprinting Disorders in Short Children Born SGA and Silver-Russell Syndrome Spectrum.印迹紊乱在小于胎龄儿和 Silver-Russell 综合征谱中的作用。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):802-813. doi: 10.1210/clinem/dgaa856.
2
DNA Methylation in the Diagnosis of Monogenic Diseases.DNA甲基化在单基因疾病诊断中的应用
Genes (Basel). 2020 Mar 26;11(4):355. doi: 10.3390/genes11040355.
3
upd(20)mat is a rare cause of the Silver-Russell-syndrome-like phenotype: Two unrelated cases and screening of large cohorts.upd(20)mat 是一种罕见的导致 Silver-Russell 综合征样表型的原因:两个不相关的病例及大样本筛查。
长距离通向综合征性身材矮小。
Ital J Pediatr. 2024 Sep 27;50(1):192. doi: 10.1186/s13052-024-01737-3.
4
Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis.多位点印记紊乱(MLID):临床和分子诊断的联合临时声明。
Clin Epigenetics. 2024 Aug 1;16(1):99. doi: 10.1186/s13148-024-01713-y.
5
Approach to the Patient With Suspected Silver-Russell Syndrome.疑似Silver-Russell综合征患者的诊疗方法
J Clin Endocrinol Metab. 2024 Sep 16;109(10):e1889-e1901. doi: 10.1210/clinem/dgae423.
6
Human Reproduction and Disturbed Genomic Imprinting.人类生殖与基因组印迹紊乱
Genes (Basel). 2024 Jan 26;15(2):163. doi: 10.3390/genes15020163.
7
Prenatal diagnosis of mosaic chromosomal aneuploidy and uniparental disomy and clinical outcomes evaluation of four fetuses.胎儿染色体嵌合非整倍体和单亲二体的产前诊断及4例胎儿临床结局评估
Mol Cytogenet. 2023 Dec 6;16(1):35. doi: 10.1186/s13039-023-00667-9.
8
Ongoing Challenges in the Diagnosis of 11p15.5-Associated Imprinting Disorders.11p15.5相关印记障碍诊断中的持续挑战
Mol Diagn Ther. 2022 May;26(3):263-272. doi: 10.1007/s40291-022-00587-1. Epub 2022 May 6.
9
Case Report: A Paternal 20q13.2-q13.32 Deletion Patient With Growth Retardation Improved by Growth Hormone.病例报告:一名患有20q13.2-q13.32父系缺失且生长发育迟缓的患者经生长激素治疗后病情改善。
Front Genet. 2022 Mar 24;13:859185. doi: 10.3389/fgene.2022.859185. eCollection 2022.
Clin Genet. 2020 Jun;97(6):902-907. doi: 10.1111/cge.13727. Epub 2020 Mar 11.
4
Molecular Etiology Disclosed by Array CGH in Patients With Silver-Russell Syndrome or Similar Phenotypes.比较基因组杂交芯片揭示的Silver-Russell综合征或相似表型患者的分子病因学
Front Genet. 2019 Oct 15;10:955. doi: 10.3389/fgene.2019.00955. eCollection 2019.
5
Contribution of GRB10 to the prenatal phenotype in Silver-Russell syndrome? Lessons from 7p12 copy number variations.GRB10对Silver-Russell综合征产前表型的影响?来自7p12拷贝数变异的启示。
Eur J Med Genet. 2019 Jul;62(7):103671. doi: 10.1016/j.ejmg.2019.103671. Epub 2019 May 14.
6
Diagnostic exome sequencing identifies haploinsufficiency and chromosome 20 uniparental disomy in a patient with developmental anomalies.诊断性外显子组测序在一名发育异常患者中鉴定出单倍剂量不足和20号染色体单亲二体。
Clin Case Rep. 2018 May 8;6(7):1208-1213. doi: 10.1002/ccr3.1575. eCollection 2018 Jul.
7
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.假性甲状旁腺功能减退症及相关疾病的诊断与管理:第一份国际共识声明。
Nat Rev Endocrinol. 2018 Aug;14(8):476-500. doi: 10.1038/s41574-018-0042-0.
8
Maternal Uniparental Disomy for Chromosome 20: Physical and Endocrinological Characteristics of Five Patients.母源性 20 号染色体单亲二体:五名患者的体格和内分泌学特征。
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2083-2088. doi: 10.1210/jc.2017-02780.
9
Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.GNAS 基因座的遗传和表观遗传缺陷导致不同的骨骼生长模式,但具有相似的早发性肥胖。
J Bone Miner Res. 2018 Aug;33(8):1480-1488. doi: 10.1002/jbmr.3450. Epub 2018 Jun 7.
10
Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction.遗传破坏致癌 HMGA2-PLAG1-IGF2 通路导致胎儿生长受限。
Genet Med. 2018 Feb;20(2):250-258. doi: 10.1038/gim.2017.105. Epub 2017 Aug 10.